Navigation Links
Logical Therapeutics Inc. Commences Double-Blind, Randomized Study of Their Lead Program, LT-NS001
Date:9/8/2008

WALTHAM, Mass., Sept. 8 /PRNewswire/ -- Logical Therapeutics, Inc., announced today the commencement of its double-blind, randomized, active-controlled, multinational study of LT-NS001, a novel prodrug, which is converted in the bloodstream to naproxen, a non-steroidal anti-inflammatory drug (NSAID). NSAIDs are the most common medications taken worldwide for the treatment of pain, inflammation, fever and arthritis, including both rheumatoid arthritis (RA) and osteoarthritis (OA).

"Despite a long history of successfully treating patients for pain and inflammation, NSAIDs have limitations that restrict their use. Gastrointestinal (GI) side effects are a significant safety problem," said Lutz Giebel, Chairman of Logical Therapeutics. Published studies have shown that NSAID use is responsible for 15-60% of hospital admissions for GI bleeding, amounting to approximately 100,000 hospitalizations and 10,000-20,000 deaths annually in the US. "A safer alternative would fulfill a significant unmet medical need," Dr. Giebel went on to say.

In pre-clinical studies in rats and dogs, LT-NS001 was shown to cause significantly less damage to the gastrointestinal tract than equivalent doses of naproxen. The study will assess gastrointestinal injury by endoscopy after 7 days of therapy. LT-NS001 was previously evaluated in two Phase 1 randomized, placebo-controlled, single-dose and multiple-dose pharmacokinetic studies. In all cases, LT-NS001 was well tolerated. Moreover, when the subjects were dosed twice daily with LT-NS001, plasma concentrations of naproxen were within the therapeutic range.

The Company also announced the departure of founding CEO, Dr. Mitchell P. Fink, who resigned to pursue other interests.

About Logical Therapeutics Inc.

Logical Therapeutics, Inc. is a privately held biotechnology company based in Waltham, Massachusetts. Logical Therapeutics is developing drugs to treat a variety of medical conditions that are associate
'/>"/>

SOURCE Logical Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. S*BIO to Develop New JAK-2 Inhibitor for Treatment of Myeloproliferative Disorders and Hematological Malignancies
2. Biological Psychiatry Publishes Study Showing VYVANSE Demonstrated Significant Efficacy for Treatment of ADHD for up to 12 Hours After Administration
3. European Commission Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for Virologically Suppressed Adults With HIV-1 Infection
4. Neurobiological Technologies, Inc. and Buck Institute Partner to Develop Novel Treatment for Alzheimers Disease
5. Nventa Announces Positive Interim Immunological Data From HspE7 Phase 1 Cervical Dysplasia Trial
6. Fifth DSMB Meeting Supports Neurobiological Technologies Continuation of Phase 3 Stroke Trials With Viprinex(TM) (ancrod)
7. Nventa Announces Additional Positive Immunological Data From HspE7 Phase 1 Cervical Dysplasia Trial
8. Neurobiological Technologies, Inc. Presents Dosing Rationale for Viprinex(TM) (ancrod) at the European Stroke Conference
9. Indevus Presents Successful Phase III NEBIDO(R) Data at American Urological Association
10. Cryoablation Is Focus of 17 Clinical Studies at American Urological Association Annual Meeting
11. TARGETED GENE DELIVERY IN VIVO: Rexin-G Monotherapy Reveals Significant Biological Activity Without Toxicity in Chemo-Resistant Metastatic Breast Cancer (ASCO 2008)

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)...ON, Pa., Nov. 6 In consultation wi...Neil Consumer Healthcare, Division of McNEIL-PPC, ...d number of product lots of TYLENOL® Arthriti...ive red EZ-OPEN CAP. McNeil is initiating the reca...taste associated with these lots that led to a sma...
(Date:11/6/2009)...6 Watson Pharmaceuticals...utical company, announced today that Paul Bisaro, ...ll provide an overview and update of the Company,s...are Conference on Wednesday, November 11, 2009 at ...ation will be webcast live and can be accessed on ...
(Date:11/6/2009)... Roper Industries, Inc. ...a definitive agreement to acquire Verathon, Inc., ... The Verathon Board of Directors has approved the...ry regulatory approvals and closing conditions, in...the closing to be completed in early December. ,...
Breaking Medicine Technology:McNeil Consumer Healthcare Announces Voluntary Recall of Certain Lots of TYLENOL(R) Arthritis Pain 100 Count with EZ-OPEN CAP 2Roper Industries Announces Two Acquisitions to Enhance Growth in Medical and Toll & Traffic Businesses 2Roper Industries Announces Two Acquisitions to Enhance Growth in Medical and Toll & Traffic Businesses 3Los Angeles fast food restaurant ban unlikely to cut obesity study finds 58909 1Los Angeles fast food restaurant ban unlikely to cut obesity study finds 58909 2Los Angeles fast food restaurant ban unlikely to cut obesity study finds 58909 3Dentist Office Music Gets A New Sound With Smile Radio 58906 1Dentist Office Music Gets A New Sound With Smile Radio 58906 2HEAL Africas Founders Conduct Nationwide Tour to Share Best Practices for Rebuilding Congo 58904 1HEAL Africas Founders Conduct Nationwide Tour to Share Best Practices for Rebuilding Congo 58904 2HEAL Africas Founders Conduct Nationwide Tour to Share Best Practices for Rebuilding Congo 58904 3
... 2007 - Results from a new,study, presented at the...ce, showed that more than 99 percent of patients w...were treated,successfully with PEGASYS(R) (peginte...n years later - validating the use of,the word "cu...y,authors. Currently, the best indicator of treatm...
...reatment for People Suffering,from Barrett,s Esoph...GTON, MASSACHUSETTS--(CCNMatthews - May 17, 2007) ...unced that the U.S. Food,and Drug Administration (...an(R) (aminolevulinic acid HCl) Photodynamic Thera.... This disease occurs in,some patients with Barret...
Other Medicine Technology:Pegasys Study Authors Conclude that Patients Successfully Treated,for Hepatitis C Can be Considered ''Cured'' 2Pegasys Study Authors Conclude that Patients Successfully Treated,for Hepatitis C Can be Considered ''Cured'' 3Pegasys Study Authors Conclude that Patients Successfully Treated,for Hepatitis C Can be Considered ''Cured'' 4Pegasys Study Authors Conclude that Patients Successfully Treated,for Hepatitis C Can be Considered ''Cured'' 5Pegasys Study Authors Conclude that Patients Successfully Treated,for Hepatitis C Can be Considered ''Cured'' 6DUSA Pharmaceuticals Receives Orphan Drug Desi gnation for Levulan,PDT to Treat Esophage al Dysplasia 2DUSA Pharmaceuticals Receives Orphan Drug Desi gnation for Levulan,PDT to Treat Esophage al Dysplasia 3DUSA Pharmaceuticals Receives Orphan Drug Desi gnation for Levulan,PDT to Treat Esophage al Dysplasia 4
(Date:11/8/2009)...my of Health holds open house at Victoria campus ...ember 8, 2009 -- UCW Academy of Health invites any...rsquo;s health care industry to attend their open ... , ,UCW Academy of Health, which offers diplomas ...l services, designs its programs to meet the needs...
(Date:11/8/2009)...e-USNewswire/ -- Speaker Nancy Pelosi and Democrat...ouse passage of H.R. 3962, the Affordable Health C... 220 to 215. Below are the Speaker,s opening rema...ived a call from the President of the United State...ory for the American people. I thank the President...
(Date:11/8/2009)... Solutions is pleased to announce that it has been...t for ReSound who recently received an award on th...e award includes not only the Veterans Administrat...federal agencies. , New Y...tions is pleased to announce that it has been succ...
(Date:11/8/2009)... 8 people in the Western District of Pennsylvania ...d suffering for a medical malpractice case. Attor...ra of Thomas E. Crenney and Associates, LLC handle...ersky and against the Uniontown Hospital. The wom...ectomy at age 18. , Pitts...
(Date:11/8/2009)...Hispanic health advocates committed to achieving m...GTON, Nov. 7 "Tonight t...heard the voice of America,s families by passing t... Senate must deliver, without delay, on the promis... L. Delgado, President and CEO of the National All...
Breaking Medicine News(10 mins):Health News:College Invites Public to Explore Career Options in Health Care 2Health News:3D Global Solutions Selected to Program Manage GN ReSound/VA Digital Hearing Aid Contract 2Health News:3D Global Solutions Selected to Program Manage GN ReSound/VA Digital Hearing Aid Contract 3Health News:Pennsylvania Jury Awards $2.3 Million to Fayette County Woman in Medical Malpractice Case 2Health News:National Alliance for Hispanic Health President and CEO Applauds House Action, Calls on Senate to Pass Health Reform in 2009 2
...hildren,s Hospital Opens,Today, PHILADELPHIA, May...now available for expectant mothers needing highly...ose Family Special,Delivery Unit at The Children,s...w.newscom.com/cgi-bin/prnh/20080520/DC23076 ), "...
...day at the International Conference of the America...ant therapy with Perforomist Inhalation Solution (...livered by nebulization, and Spiriva (tiotropium; ...g-term, twice-daily maintenance treatment of bronc...
...rectors of BD (Becton, Dickinson and Company) (NYS...5 cents per common share. The dividend will be,pay... 9, 2008. The,indicated annual dividend rate is $1...ts, is dedicated to,improving people,s health thro...
...lletin Board: SYMD) announced today that its Board...er rights plan. The shareholder rights plan is,des...ue and equal treatment,in the event of an attempte... a result of any specific takeover attempt., To i...
...nse of competence, study suggests , , TUES...can affect your ability to make sense of what you ...ke-NUS Graduate Medical School in Singapore shows....ear-normal brain function in which they were able ...
...amsey is,holding a Free informational seminar for .... Dr. Ramsey together with Dr. Jessica Marier will...ht differently -- and what,women can do to even ou...8 from 1:00-3:00pm. Please join us for this,intera...
Other Medicine News:Health News:The Children's Hospital of Philadelphia Opens the World's First Delivery Unit for Mothers Diagnosed with Birth Defects in Fetus 2Health News:The Children's Hospital of Philadelphia Opens the World's First Delivery Unit for Mothers Diagnosed with Birth Defects in Fetus 3Health News:The Children's Hospital of Philadelphia Opens the World's First Delivery Unit for Mothers Diagnosed with Birth Defects in Fetus 4Health News:Concomitant use of Perforomist & tiotropium -- significant improvements -- COPD 2Health News:SyntheMed, Inc. Adopts Shareholder Rights Plan 2Health News:Sleep-Deprived Brains Show Lapse in Visual Processing 2
Replacement Bulb: UXL-150M-O
Replacement Bulb: USH-200DP
Replacement Bulb: USH-102D
Replacement Bulb: HTI 250W/32C
Medicine Products: